These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Involvement of brain trace amines in the behavioural effects of phenelzine. Dewar KM, Dyck LE, Durden DA, Boulton AA. Neurochem Res; 1988 Feb; 13(2):113-9. PubMed ID: 3362290 [Abstract] [Full Text] [Related]
24. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, Coutts RT. J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558 [Abstract] [Full Text] [Related]
25. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R, Olmos G, García-Sevilla JA. Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [Abstract] [Full Text] [Related]
31. The influence of L-tryptophan and monoamine oxidase inhibitors on catecholamine metabolism in rat brain. Eccleston D, Nicolaou N. Br J Pharmacol; 1978 Nov; 64(3):341-5. PubMed ID: 719232 [Abstract] [Full Text] [Related]
33. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S. Chem Biol Interact; 2019 May 01; 304():139-147. PubMed ID: 30857888 [Abstract] [Full Text] [Related]
39. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Cohen RM, Campbell IC, Dauphin M, Tallman JF, Murphy DL. Neuropharmacology; 1982 Apr 01; 21(4):293-8. PubMed ID: 6123960 [Abstract] [Full Text] [Related]